Sale!

BMP1 Gene Osteogenesis Imperfecta Type 13 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The BMP1 gene plays a critical role in bone development and repair, and mutations in this gene are associated with Osteogenesis Imperfecta (OI) Type 13, a rare form of brittle bone disease. The BMP1 Gene Osteogenesis Imperfecta Type 13 Genetic Test is a specialized diagnostic tool used to detect specific mutations in the BMP1 gene that are linked to this condition. This test is vital for early diagnosis, allowing for appropriate management and treatment plans to be established for affected individuals.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the BMP1 gene to identify the presence of disease-causing mutations. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately diagnose this rare genetic disorder. Early detection through this test can significantly improve the quality of life for individuals with Osteogenesis Imperfecta Type 13 by enabling targeted interventions and support.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

BMP1 Gene Osteogenesis imperfecta type 13 Genetic Test

Test Details

The BMP1 gene is associated with osteogenesis imperfecta type 13, a rare genetic disorder characterized by brittle bones that are prone to fractures. NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that allows for the analysis of multiple genes simultaneously. In the context of genetic testing for osteogenesis imperfecta type 13, NGS can be used to sequence the BMP1 gene to identify any mutations or variations that may be present.

The NGS genetic test for BMP1 gene mutations can help confirm a diagnosis of osteogenesis imperfecta type 13 in individuals with suspected symptoms of the condition. It can also be used for carrier testing in individuals with a family history of the disorder.

Genetic testing can provide valuable information for individuals and families affected by osteogenesis imperfecta type 13, including genetic counseling, management strategies, and potentially targeted treatments in the future. It is important to consult with a healthcare professional or genetic counselor to understand the implications and limitations of the test results.

Test Name

BMP1 Gene Osteogenesis imperfecta type 13 Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test type

Osteology Dermatology Immunology Disorders

Doctor

Dermatologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for BMP1 Gene Osteogenesis imperfecta type 13 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with BMP1 Gene Osteogenesis imperfecta type 13 NGS Genetic DNA Test gene BMP1

For more information or to schedule an appointment, please contact DNA Labs UAE.

Test Name BMP1 Gene Osteogenesis imperfecta type 13 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for BMP1 Gene Osteogenesis imperfecta type 13 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with BMP1 Gene Osteogenesis imperfecta type 13 NGS Genetic DNA Test gene BMP1
Test Details

The BMP1 gene is associated with osteogenesis imperfecta type 13, a rare genetic disorder characterized by brittle bones that are prone to fractures.

NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that allows for the analysis of multiple genes simultaneously. In the context of genetic testing for osteogenesis imperfecta type 13, NGS can be used to sequence the BMP1 gene to identify any mutations or variations that may be present.

The NGS genetic test for BMP1 gene mutations can help confirm a diagnosis of osteogenesis imperfecta type 13 in individuals with suspected symptoms of the condition. It can also be used for carrier testing in individuals with a family history of the disorder.

Genetic testing can provide valuable information for individuals and families affected by osteogenesis imperfecta type 13, including genetic counseling, management strategies, and potentially targeted treatments in the future. It is important to consult with a healthcare professional or genetic counselor to understand the implications and limitations of the test results.